Table 4.
Laboratory data. Association between blood test values and ONS intake.
| CF | CF | ||||
|---|---|---|---|---|---|
| Total | No ONS (n = 46) |
ONS (n = 13) |
p | ||
| Blood test data (n = 59) | |||||
| Vitamin A (mcg/dl) | (m ± SD) | 46.4 ± 20.1 | 46.4 ± 19.8 | 46.6 ± 21.9 | NS |
| <20 | n (%) | 2 (3.4) | 1 (2.2) | 1 (7.7) | NS |
| 25-OH-Vitamin D (mcg/dl) | (m ± SD) | 38.1 ± 28.6 | 37.4 ± 31.3 | 40.6 ± 15.1 | NS |
| <20 | n (%) | 13 (22.0) | 13 (28.3) | 0 (0) | <0.05 |
| >30 | n (%) | 29 (49.2) | 21 (45.6) | 8 (61.5) | |
| Vitamin E (mg/g) | (m ± SD) | 1248.2 ± 413.8 | 1174.3 ± 396.6 | 1488.3 ± 390.9 | <0.05 |
| <800 | n (%) | 6 (10.2) | 6 (12.8) | 0 (0) | NS |
| Vitamin E/Cholesterol | (m ± SD) | 9.18 ± 3.30 | 8.3 ± 2.9 | 12.0 ± 3.0 | <0.001 |
| <5,7 | n (%) | 2 (3.4) | 2 (5.3) | 0 (0) | NS |
| Prothrombin time (%) | (m ± SD) | 97.1 ± 11.9 | 97.4 ± 11.8 | 95.7 ± 13.3 | NS |
| ucOC (ng/mL) | (m ± SD) | 4.7 ± 2.7 | 4.7 ± 2.7 | 4.7 ± 2.4 | NS |
| OC (ng/mL) | (m ± SD) | 26.4 ± 25.9 | 27.5 ± 26.7 | 22.0 ± 23.4 | NS |
| CTX (mcg/mL) | (m ± SD) | 0.55 ± 0.30 | 0.53 ± 0.30 | 0.63 ± 0.35 | NS |
| RANKL (pmol/L) | (m ± SD) | 0.23 ± 0.28 | 0.18 ± 0.22 | 0.42 ± 0.42 | <0.05 |
CTX: degradation of the C-terminal telopeptides of type I collagen; RANKL: receptor activator of nuclear factor-kappaB ligand; OC osteocalcin; ucOC: undercarboxylated osteocalcin; m ± SD: mean ± standard deviation; NS: Not significant; p: statistical significance between ONS and No ONS.